Multiple sclerosis (MS) is a chronic, autoimmune, demyelinating disease of the central
nervous system (CNS). MS is an incurable disease. The goal of disease-modifying therapies …

Comorbid conditions commonly affect people with multiple sclerosis (MS). Population-based
studies indicate that people with MS have an increased incidence of ischemic heart disease …

Background/objectives Several studies supported the beneficial effects of the Mediterranean
diet (MeDi) on chronic diseases. In Multiple Sclerosis (MS), the MeDi might interfere with …

Background and purpose Cardiovascular risk factors and comorbidities can affect the
prognosis of multiple sclerosis (MS). The Framingham risk score is an algorithm that can …

Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative disease of the
central nervous system (CNS) affecting more than two million people worldwide. In MS …

Background: With many options now available, first therapy choice is challenging in multiple
sclerosis (MS) and depends mainly on neurologist and patient preferences. Objectives: To …

Purpose Multiple sclerosis (MS) is an inflammatory and degenerative condition affecting the
central nervous system. Like many neurologic diseases, it is chronic and incurable, and …

Introduction: Although multiple sclerosis (MS) remains incurable, interferon beta (IFNβ) has
been at the forefront of treatment for many years. Different formulations of IFNβ allow for …

The available data, including experimental studies, clearly indicate an excessive
intravascular activation of circulating platelets in multiple sclerosis (MS) and their hyper …

Multiple sclerosis (MS) is an autoimmune disease characterized by a robust inflammatory
response against myelin sheath antigens, which causes astrocyte and microglial activation …